These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29575410)

  • 41. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Validity and reliability of the St George's Respiratory Questionnaire in adults with cystic fibrosis].
    Padilla A; Olveira G; Olveira C; Dorado A; Plata AJ; Gaspar I; Pérez-Frías J
    Arch Bronconeumol; 2007 Apr; 43(4):205-11. PubMed ID: 17397584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 44. [Validation of the Polish version of St. George's respiratory questionnaire in patients with bronchial asthma].
    Kuźniar T; Patkowski J; Liebhart J; Wytrychowski K; Dobek R; Slusarz R; Liebhart E; Małolepszy J
    Pneumonol Alergol Pol; 1999; 67(11-12):497-503. PubMed ID: 11057099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Kida K
    J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nutritional supplementation for stable chronic obstructive pulmonary disease.
    Ferreira IM; Brooks D; White J; Goldstein R
    Cochrane Database Syst Rev; 2012 Dec; 12():CD000998. PubMed ID: 23235577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis.
    Vodanovich DA; Bicknell TJ; Holland AE; Hill CJ; Cecins N; Jenkins S; McDonald CF; Burge AT; Thompson P; Stirling RG; Lee AL
    Respiration; 2015; 90(2):89-96. PubMed ID: 26088151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of health-related quality of life in patients with interstitial lung disease.
    Chang JA; Curtis JR; Patrick DL; Raghu G
    Chest; 1999 Nov; 116(5):1175-82. PubMed ID: 10559073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the St. George's Respiratory Questionnaire in bronchiectasis.
    Wilson CB; Jones PW; O'Leary CJ; Cole PJ; Wilson R
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):536-41. PubMed ID: 9279236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary-specific quality of life and dyspnea among patients hospitalized for coronavirus disease 2019: Evaluation of patient groups 1, 3 and 6 months after discharge.
    Doğantekin B; Güney BÇ; Ekinci SÇ; Serindağ Z; Tükel N; Işık SA; Kılıç S; Kaplan M
    Adv Clin Exp Med; 2023 Nov; 32(11):1233-1240. PubMed ID: 37093090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis.
    McLeese RH; Spinou A; Alfahl Z; Tsagris M; Elborn JS; Chalmers JD; De Soyza A; Loebinger MR; Birring SS; Fragkos KC; Wilson R; O'Neill K; Bradley JM
    Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 33888521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interpretation of quality of life scores from the St George's Respiratory Questionnaire.
    Ferrer M; Villasante C; Alonso J; Sobradillo V; Gabriel R; Vilagut G; Masa JF; Viejo JL; Jiménez-Ruiz CA; Miravitlles M
    Eur Respir J; 2002 Mar; 19(3):405-13. PubMed ID: 11936515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease?
    Takao S; Tabusadani M; Yamane K; Kakuta T; Kuroyama Y; Mori K; Ono K; Omatsu S; Kawahara K; Toyoda Y; Senjyu H
    Respir Investig; 2021 Jan; 59(1):120-125. PubMed ID: 32800755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease.
    Matsuda T; Kondoh Y; Takei R; Sasano H; Fukihara J; Yamano Y; Yokoyama T; Kataoka K; Watanabe F; Kimura T
    Respir Investig; 2024 Sep; 62(6):1088-1093. PubMed ID: 39332275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects.
    Małysiak-Szpond S; Mozga M; Miądlikowska E; Miłkowska-Dymanowska J; Białas AJ; Piotrowski WJ
    PLoS One; 2022; 17(12):e0278601. PubMed ID: 36574413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
    Donohue JF; Bollu VK; Stull DE; Nelson LM; Williams VS; Stensland MD; Hanania NA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():499-508. PubMed ID: 29440887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease.
    Bourbeau J; Maltais F; Rouleau M; Guímont C
    Can Respir J; 2004 Oct; 11(7):480-6. PubMed ID: 15505701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [St. George's Hospital questionnaire (St. George's Respiratory Questionnaire) as an instrument for quality of life assessment in respiratory tract diseases].
    Kuźniar T; Patkowski J
    Pol Arch Med Wewn; 2000 Jul; 104(1):401-12. PubMed ID: 11303332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.